查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1193270

外科粘合劑市場：按產品、應用、最終用戶分類：2021-2031 年全球機遇分析和行業預測

Surgical Glue Market By Product, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 290 Pages | 商品交期: 2-3個工作天內

價格

2021 年全球手術粘合劑市場價值 23.4071 億美元，預計到 2031 年將達到 46.1485 億美元，2022 年至 2031 年的複合年增長率為 7.0%。

手術膠在不同的小瓶中包含兩種成分：凝血蛋白凍乾濃縮物，以纖維蛋白原、因子 XIII 和纖連蛋白（密封劑）和凍乾凝血□（催化劑）為中心。包括在內。 第一種成分用抑制組織纖維蛋白溶解的抑□□溶液重構。 第二種成分（凝血□）溶解在氯化鈣中，濃度為 500 I.U. 人體纖維蛋白密封劑的適應症很多，存在於所有手術系統中。 它還能有效預防並發凝血病患者腹股溝疝修補術後的局部出血並發症。

由於老年人口增加、手術數量增加以及受傷發生率增加，預計全球手術粘合劑市場在預測期內將出現顯著的市場增長。 此外，交通事故的增加、外科粘合劑意識的提高以及慢性病患病率的增加都對市場增長做出了重大貢獻。 然而，手術粘合劑的高成本、替代品的可用性以及微創手術的不受歡迎對市場增長產生了負面影響。 相反，新興國家的高增長潛力為市場增長提供了有利可圖的機會。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章手術粘合劑市場，按產品分類

  • 概覽
    • 市場規模和預測
  • 自然的
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 合成/半合成
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章手術粘合劑市場：按應用

  • 概覽
    • 市場規模和預測
  • 中樞神經系統手術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 普通外科
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 心血管外科
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 骨科手術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 整容手術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 眼科手術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 泌尿外科
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 肺部手術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章手術粘合劑市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 門診手術中心
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章手術粘合劑市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按產品
    • 北美市場規模和預測：按應用
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按產品
    • 歐洲市場規模和預測：按應用分類
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機會
    • 亞太市場規模和預測：按產品
    • 亞太市場規模和預測：按應用
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按產品
    • LAMEA 市場規模和預測：按應用分類
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Cohera Medical, Inc.
  • CryoLife Inc.
  • CSL Limited
  • Johnson & Johnson
  • Ocular Therapeutix Inc.
  • Sanofi
  • Sealantis Ltd.
  • Vivostat
Product Code: A31580

The global surgical glue market was valued at $2,340.71 million in 2021, and is projected to reach $4,614.85 million by 2031, registering a CAGR of 7.0% from 2022 to 2031.

Surgical glue is made of two components contained in separate vials; a freeze dried concentrate of clotting proteins, mainly fibrinogen, Factor XIII and fibronectin (the sealant) and freeze dried thrombin (the catalyst). The first component is reconstituted with an aprotinin solution that inhibits tissue fibrinolysis. The second component (thrombin) is dissolved with calcium chloride that is available in 500 I.U. concentration. Indications for the use of human fibrin sealant are numerous and present in all surgical branches. It is also effective in preventing local hemorrhagic complications after inguinal hernia repair in patients with concurrent coagulation disorders.

The global surgical glue market is anticipated to show significant market growth during the forecast period, owing to increase in geriatric population, increase in number of surgical procedures performed, and increase in incidence of wounds and injuries. Furthermore, increase in number of road accidents, increase in awareness regarding surgical glue and increase in prevalence of chronic diseases are considerably contributing toward the market growth. However, high cost of surgical glues and availability of alternate products and unpopularity of minimally invasive surgeries are negatively impacting the market growth. Conversely, the high growth potential in emerging countries offers lucrative opportunities for growth of the market.

The global surgical glue market is segmented on the basis of product, application, end user, and region. By product, the market is classified into natural and synthetic & semi-synthetic. By application, it is classified into central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. By end user, it is classified into hospitals, ambulatory surgery centers, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major companies profiled in the report include Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Integra Lifesciences Corporation, Johnson & Johnson, Medtronic plc, Ocular Therapeutix Inc., and OptMed, Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical glue market analysis from 2021 to 2031 to identify the prevailing surgical glue market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the surgical glue market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global surgical glue market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Product

  • Natural
  • Synthetic and Semi Synthetic

By Application

  • Central Nervous System Surgeries
  • General Surgeries
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Cosmetic Surgeries
  • Ophthalmic Surgeries
  • Urological Surgeries
  • Pulmonary Surgeries
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Cohera Medical, Inc.
    • CryoLife Inc.
    • CSL Limited
    • Johnson & Johnson
    • Ocular Therapeutix Inc.
    • Sanofi
    • Sealantis Ltd.
    • Vivostat

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SURGICAL GLUE MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Natural
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Synthetic and Semi Synthetic
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: SURGICAL GLUE MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Central Nervous System Surgeries
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 General Surgeries
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4 Cardiovascular Surgeries
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country
  • 5.5 Orthopedic Surgeries
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market share analysis by country
  • 5.6 Cosmetic Surgeries
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market share analysis by country
  • 5.7 Ophthalmic Surgeries
    • 5.7.1 Key market trends, growth factors and opportunities
    • 5.7.2 Market size and forecast, by region
    • 5.7.3 Market share analysis by country
  • 5.8 Urological Surgeries
    • 5.8.1 Key market trends, growth factors and opportunities
    • 5.8.2 Market size and forecast, by region
    • 5.8.3 Market share analysis by country
  • 5.9 Pulmonary Surgeries
    • 5.9.1 Key market trends, growth factors and opportunities
    • 5.9.2 Market size and forecast, by region
    • 5.9.3 Market share analysis by country
  • 6.0 Others
    • 6.0.1 Key market trends, growth factors and opportunities
    • 6.0.2 Market size and forecast, by region
    • 6.0.3 Market share analysis by country

CHAPTER 6: SURGICAL GLUE MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: SURGICAL GLUE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End user
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product
      • 7.2.5.1.3 Market size and forecast, by Application
      • 7.2.5.1.4 Market size and forecast, by End user
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product
      • 7.2.5.2.3 Market size and forecast, by Application
      • 7.2.5.2.4 Market size and forecast, by End user
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product
      • 7.2.5.3.3 Market size and forecast, by Application
      • 7.2.5.3.4 Market size and forecast, by End user
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End user
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product
      • 7.3.5.1.3 Market size and forecast, by Application
      • 7.3.5.1.4 Market size and forecast, by End user
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product
      • 7.3.5.2.3 Market size and forecast, by Application
      • 7.3.5.2.4 Market size and forecast, by End user
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product
      • 7.3.5.3.3 Market size and forecast, by Application
      • 7.3.5.3.4 Market size and forecast, by End user
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product
      • 7.3.5.4.3 Market size and forecast, by Application
      • 7.3.5.4.4 Market size and forecast, by End user
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product
      • 7.3.5.5.3 Market size and forecast, by Application
      • 7.3.5.5.4 Market size and forecast, by End user
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product
      • 7.3.5.6.3 Market size and forecast, by Application
      • 7.3.5.6.4 Market size and forecast, by End user
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End user
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product
      • 7.4.5.1.3 Market size and forecast, by Application
      • 7.4.5.1.4 Market size and forecast, by End user
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product
      • 7.4.5.2.3 Market size and forecast, by Application
      • 7.4.5.2.4 Market size and forecast, by End user
      • 7.4.5.3 India
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product
      • 7.4.5.3.3 Market size and forecast, by Application
      • 7.4.5.3.4 Market size and forecast, by End user
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product
      • 7.4.5.4.3 Market size and forecast, by Application
      • 7.4.5.4.4 Market size and forecast, by End user
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product
      • 7.4.5.5.3 Market size and forecast, by Application
      • 7.4.5.5.4 Market size and forecast, by End user
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product
      • 7.4.5.6.3 Market size and forecast, by Application
      • 7.4.5.6.4 Market size and forecast, by End user
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End user
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product
      • 7.5.5.1.3 Market size and forecast, by Application
      • 7.5.5.1.4 Market size and forecast, by End user
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product
      • 7.5.5.2.3 Market size and forecast, by Application
      • 7.5.5.2.4 Market size and forecast, by End user
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product
      • 7.5.5.3.3 Market size and forecast, by Application
      • 7.5.5.3.4 Market size and forecast, by End user
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product
      • 7.5.5.4.3 Market size and forecast, by Application
      • 7.5.5.4.4 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Baxter International Inc.
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 B. Braun Melsungen AG
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Cohera Medical, Inc.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 CryoLife Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 CSL Limited
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Johnson & Johnson
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Ocular Therapeutix Inc.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Sanofi
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Sealantis Ltd.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Vivostat
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. SURGICAL GLUE MARKET FOR NATURAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. SURGICAL GLUE MARKET FOR NATURAL, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. SURGICAL GLUE MARKET FOR SYNTHETIC AND SEMI SYNTHETIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. SURGICAL GLUE MARKET FOR SYNTHETIC AND SEMI SYNTHETIC, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. GLOBAL SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. SURGICAL GLUE MARKET FOR CENTRAL NERVOUS SYSTEM SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. SURGICAL GLUE MARKET FOR CENTRAL NERVOUS SYSTEM SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. SURGICAL GLUE MARKET FOR GENERAL SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. SURGICAL GLUE MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. SURGICAL GLUE MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. SURGICAL GLUE MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. SURGICAL GLUE MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. SURGICAL GLUE MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. SURGICAL GLUE MARKET FOR COSMETIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. SURGICAL GLUE MARKET FOR COSMETIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. SURGICAL GLUE MARKET FOR OPHTHALMIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. SURGICAL GLUE MARKET FOR OPHTHALMIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. SURGICAL GLUE MARKET FOR UROLOGICAL SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. SURGICAL GLUE MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. SURGICAL GLUE MARKET FOR PULMONARY SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. SURGICAL GLUE MARKET FOR PULMONARY SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. SURGICAL GLUE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. SURGICAL GLUE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. GLOBAL SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. SURGICAL GLUE MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. SURGICAL GLUE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. SURGICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. SURGICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. SURGICAL GLUE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. SURGICAL GLUE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. SURGICAL GLUE MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. NORTH AMERICA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. NORTH AMERICA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. NORTH AMERICA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. NORTH AMERICA SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. U.S. SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. U.S. SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. U.S. SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. CANADA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. CANADA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. CANADA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. MEXICO SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. MEXICO SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. MEXICO SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. EUROPE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. EUROPE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. EUROPE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. EUROPE SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. GERMANY SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. GERMANY SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. GERMANY SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. FRANCE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. FRANCE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. FRANCE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. UK SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. UK SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. UK SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. ITALY SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. ITALY SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. ITALY SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. SPAIN SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. SPAIN SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. SPAIN SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. REST OF EUROPE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. REST OF EUROPE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF EUROPE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. ASIA-PACIFIC SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. ASIA-PACIFIC SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. ASIA-PACIFIC SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. ASIA-PACIFIC SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. JAPAN SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. JAPAN SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. JAPAN SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. CHINA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. CHINA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. CHINA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. INDIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. INDIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. INDIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. AUSTRALIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. AUSTRALIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. AUSTRALIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH KOREA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SOUTH KOREA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. SOUTH KOREA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. LAMEA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. LAMEA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. LAMEA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. LAMEA SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94. BRAZIL SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 95. BRAZIL SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 96. BRAZIL SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 97. SAUDI ARABIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 98. SAUDI ARABIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 99. SAUDI ARABIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 100. SOUTH AFRICA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 101. SOUTH AFRICA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 102. SOUTH AFRICA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 103. REST OF LAMEA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 104. REST OF LAMEA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 105. REST OF LAMEA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 106.BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 107.BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
  • TABLE 108.BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 109.BAXTER INTERNATIONAL INC.: NET SALES
  • TABLE 110.BAXTER INTERNATIONAL INC.: KEY STRATERGIES
  • TABLE 111.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 112.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 113.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 114.B. BRAUN MELSUNGEN AG: NET SALES
  • TABLE 115.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
  • TABLE 116.COHERA MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 117.COHERA MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 118.COHERA MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 119.COHERA MEDICAL, INC.: NET SALES
  • TABLE 120.COHERA MEDICAL, INC.: KEY STRATERGIES
  • TABLE 121.CRYOLIFE INC.: COMPANY SNAPSHOT
  • TABLE 122.CRYOLIFE INC.: OPERATING SEGMENTS
  • TABLE 123.CRYOLIFE INC.: PRODUCT PORTFOLIO
  • TABLE 124.CRYOLIFE INC.: NET SALES
  • TABLE 125.CRYOLIFE INC.: KEY STRATERGIES
  • TABLE 126.CSL LIMITED: COMPANY SNAPSHOT
  • TABLE 127.CSL LIMITED: OPERATING SEGMENTS
  • TABLE 128.CSL LIMITED: PRODUCT PORTFOLIO
  • TABLE 129.CSL LIMITED: NET SALES
  • TABLE 130.CSL LIMITED: KEY STRATERGIES
  • TABLE 131.JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 132.JOHNSON & JOHNSON: OPERATING SEGMENTS
  • TABLE 133.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 134.JOHNSON & JOHNSON: NET SALES
  • TABLE 135.JOHNSON & JOHNSON: KEY STRATERGIES
  • TABLE 136.OCULAR THERAPEUTIX INC.: COMPANY SNAPSHOT
  • TABLE 137.OCULAR THERAPEUTIX INC.: OPERATING SEGMENTS
  • TABLE 138.OCULAR THERAPEUTIX INC.: PRODUCT PORTFOLIO
  • TABLE 139.OCULAR THERAPEUTIX INC.: NET SALES
  • TABLE 140.OCULAR THERAPEUTIX INC.: KEY STRATERGIES
  • TABLE 141.SANOFI: COMPANY SNAPSHOT
  • TABLE 142.SANOFI: OPERATING SEGMENTS
  • TABLE 143.SANOFI: PRODUCT PORTFOLIO
  • TABLE 144.SANOFI: NET SALES
  • TABLE 145.SANOFI: KEY STRATERGIES
  • TABLE 146.SEALANTIS LTD.: COMPANY SNAPSHOT
  • TABLE 147.SEALANTIS LTD.: OPERATING SEGMENTS
  • TABLE 148.SEALANTIS LTD.: PRODUCT PORTFOLIO
  • TABLE 149.SEALANTIS LTD.: NET SALES
  • TABLE 150.SEALANTIS LTD.: KEY STRATERGIES
  • TABLE 151.VIVOSTAT: COMPANY SNAPSHOT
  • TABLE 152.VIVOSTAT: OPERATING SEGMENTS
  • TABLE 153.VIVOSTAT: PRODUCT PORTFOLIO
  • TABLE 154.VIVOSTAT: NET SALES
  • TABLE 155.VIVOSTAT: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.SURGICAL GLUE MARKET SEGMENTATION
  • FIGURE 2.SURGICAL GLUE MARKET,2021-2031
  • FIGURE 3.SURGICAL GLUE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.SURGICAL GLUE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.SURGICAL GLUE MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NATURAL SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SYNTHETIC AND SEMI SYNTHETIC SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 15.SURGICAL GLUE MARKET,BY APPLICATION,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CENTRAL NERVOUS SYSTEM SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF GENERAL SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF COSMETIC SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OPHTHALMIC SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF UROLOGICAL SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PULMONARY SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 25.SURGICAL GLUE MARKET,BY END USER,2021(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF OTHERS SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 29.SURGICAL GLUE MARKET BY REGION,2021
  • FIGURE 30.U.S. SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 31.CANADA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 32.MEXICO SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 33.GERMANY SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 34.FRANCE SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 35.UK SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 36.ITALY SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 37.SPAIN SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 38.REST OF EUROPE SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 39.JAPAN SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 40.CHINA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 41.INDIA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 42.AUSTRALIA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH KOREA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF ASIA-PACIFIC SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 45.BRAZIL SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 46.SAUDI ARABIA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 47.SOUTH AFRICA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 48.REST OF LAMEA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 53.COMPETITIVE DASHBOARD
  • FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 55.BAXTER INTERNATIONAL INC..: NET SALES ($MILLION)
  • FIGURE 56.B. BRAUN MELSUNGEN AG.: NET SALES ($MILLION)
  • FIGURE 57.COHERA MEDICAL, INC..: NET SALES ($MILLION)
  • FIGURE 58.CRYOLIFE INC..: NET SALES ($MILLION)
  • FIGURE 59.CSL LIMITED.: NET SALES ($MILLION)
  • FIGURE 60.JOHNSON & JOHNSON.: NET SALES ($MILLION)
  • FIGURE 61.OCULAR THERAPEUTIX INC..: NET SALES ($MILLION)
  • FIGURE 62.SANOFI.: NET SALES ($MILLION)
  • FIGURE 63.SEALANTIS LTD..: NET SALES ($MILLION)
  • FIGURE 64.VIVOSTAT.: NET SALES ($MILLION)